Tamoxifen-resistant BC cells (MCF-7 and T47D) were observed to overexpress CCAT2, while CCAT2 knockdown promoted apoptosis and diminished cell proliferation, improving the tamoxifen sensitivity [23]. This evidence concerns the gene CCAT2 and breast cancer.